PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer

PD-L1 expression varies across different TC types and histological subtypes and may be modulated by the mutational landscape. PD-L1 expression in ATC is associated with shorter PFS. Follow up studies are warranted to elucidate the molecular mechanism driving the observed differences in immune pathways, potentially paving the way for the development of more effective and personalized immune therapies for patients with aggressive TC.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2024-10-28
DOI
https://doi.org/10.3390/cancers16213632
Citations
7
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer

Jennifer E. Rosen, Leonard Wartofsky, Deema Al-Souri, Kenneth D. Burman et al.
7 citations
Cancers
Thyroid Cancer Diagnosis and Treatment
2.50
article

PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer

Jennifer E. Rosen, Leonard Wartofsky, Deema Al-Souri, Kenneth D. Burman, Jiling Chou, Leila Shobab, Joanna Kłubo-Gwieździńska, Liza Mathews, Michael B. Atkins, William Kuenstner, Matthew McCoy, Vasyl Vasko, Wen Lee, Gretchen K. Hubbard, Sonam Kumari
article en
7 citations

Abstract

PD-L1 expression varies across different TC types and histological subtypes and may be modulated by the mutational landscape. PD-L1 expression in ATC is associated with shorter PFS. Follow up studies are warranted to elucidate the molecular mechanism driving the observed differences in immune pathways, potentially paving the way for the development of more effective and personalized immune therapies for patients with aggressive TC.

CancersVol. 16(21)
MedStar Washington Hospital Center (US), National Institutes of Health (US), Uniformed Services University of the Health Sciences (US), Georgetown University (US), Georgetown University Medical Center (US), MedStar Georgetown University Hospital (US), National Institute of Diabetes and Digestive and Kidney Diseases (US), Caris Life Sciences (United States) (US), MedStar Health (US)
Good health and well-being
Openalex Percentile: Top 9%
Thyroid Cancer Diagnosis and Treatment
2.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.